Byers Capital — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Arsenal Biosciencesarsenalbio.comSep 2024

Arsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors.

BiotechHealthtechMedical DevicesSouth San Francisco, US

Ken Drazan(Founder)James Ahlers(Executive Officer)Irene Pleasure(Executive Officer)Margaret Nibbi(Executive Officer)Alexander Marson(Founder)Kole Roybal(Founder)

Co-investorsARCH Venture Partners Hitachi Ventures Kleiner Perkins Luma Group OUP (Osage University Partners)SoftBank Vision Fund +4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.